The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Clostridium difficile–Associated Diarrhea: A Review
Abstract
Clostridium difficile causes 300 000 to 3 000 000 cases of diarrhea and colitis in the United States every year. Antibiotics most frequently associated with the infection are clindamycin, ampicillin, amoxicillin, and cephalosporins, but all antibiotics may predispose patients to C difficile infection. The clinical presentation varies from asymptomatic colonization to mild diarrhea to severe debilitating disease, with high fever, severe abdominal pain, paralytic ileus, colonic dilation (or megacolon), or even perforation. The most sensitive and specific test available for diagnosis of C difficile infection is a tissue culture assay for the cytotoxicity of toxin B. However, this test takes 1 to 3 days to complete and requires tissue culture facilities. Detection of C difficile toxin by means of enzyme-linked immunoassay is more rapid and inexpensive. A minority of patients may require more than 1 stool assay to detect toxin. Oral metronidazole or oral vancomycin hydrochloride for 10 to 14 days are equally effective at resolving clinical symptoms; oral metronidazole is preferred in most cases because of lowered cost and less selective pressure for vancomycin-resistant organisms. Approximately 15% of patients experience relapse after initial therapy and require retreatment, sometimes with an extended, tapering regimen. Immunity appears to be incomplete and predominantly mediated by serum IgG to toxin A. Measures for preventing the spread of the pathogen, appropriate diagnostic testing, and treatment may avert morbidity and mortality due to C difficile-associated diarrhea.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Craig, W. A. (1998) · Clinical Infectious Diseases · doi:10.1086/516284 · Cited by 2,908
Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia
Bartlett, J. G., Chang, T. W., Gurwith, M., Gorbach, S. L., & Onderdonk, A. B. (1978) · New England Journal of Medicine · doi:10.1056/nejm197803092981003 · Cited by 1,374
Nosocomial Acquisition of Clostridium difficile Infection
McFarland, L. V., Mulligan, M. E., Kwok, R. Y. Y., & Stamm, W. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901263200402 · Cited by 1,326
Kelly, C. P., Pothoulakis, C., & LaMont, J. T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300406 · Cited by 1,321
Practice Guidelines for the Management of Infectious Diarrhea
Guerrant, R. L., Van Gilder, T., Steiner, T. S., Thielman, N. M., Slutsker, L., Tauxe, R. V., Hennessy, T., Griffin, P. M., DuPont, H., Bradley Sack, R., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/318514 · Cited by 1,074
Glucosylation of Rho proteins by Clostridium difficile toxin B
Just, I., Selzer, J., Wilm, M., Eichel-Streiber, C. V., Mann, M., & Aktories, K. (1995) · Nature · doi:10.1038/375500a0 · Cited by 1,032
Asymptomatic Carriage of Clostridium difficile and Serum Levels of IgG Antibody against Toxin A
Kyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420604 · Cited by 935
Health Care Costs and Mortality Associated with Nosocomial Diarrhea Due to Clostridium difficile
Kyne, L., Hamel, M. B., Polavaram, R., & Kelly, C. P. (2002) · Clinical Infectious Diseases · doi:10.1086/338260 · Cited by 904
McFarland, L. V. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510480037031 · Cited by 857
Kyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03592-3 · Cited by 804
HALL, I. C. (1935) · American Journal of Diseases of Children · doi:10.1001/archpedi.1935.01970020105010 · Cited by 772
Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis
D'Souza, A. L., Rajkumar, C., Cooke, J., & Bulpitt, C. J. (2002) · BMJ · doi:10.1136/bmj.324.7350.1361 · Cited by 664
Clostridium Difficile-Associated Diarrhea and Colitis
Gerding, D. N., Johnson, S., Peterson, L. R., Mulligan, M. E., & Silva, J. (1995) · Infection Control & Hospital Epidemiology · doi:10.1086/648363 · Cited by 631
Fulminant Clostridium difficile: An Underappreciated and Increasing Cause of Death and Complications
Dallal, R. M., Harbrecht, B. G., Boujoukas, A. J., Sirio, C. A., Farkas, L. M., Lee, K. K., & Simmons, R. L. (2002) · Annals of Surgery · doi:10.1097/00000658-200203000-00008 · Cited by 628
Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis
Bartlett, J. G., Moon, N., Chang, T. W., Taylor, N., & Onderdonk, A. B. (1978) · Gastroenterology · doi:10.1016/0016-5085(78)90457-2 · Cited by 517
Wenisch, C., Parschalk, B., Hasenhundl, M., Hirschl, A. M., & Graninger, W. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.5.813 · Cited by 505
BACTERIOTHERAPY FOR CHRONIC RELAPSING CLOSTRIDIUM DIFFICILE DIARRHOEA IN SIX PATIENTS
Tvede, M., & Rask-Madsen, J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92749-9 · Cited by 491
The Enterotoxin from Clostridium difficile (ToxA) Monoglucosylates the Rho Proteins
Just, I., Wilm, M., Selzer, J., Rex, G., von Eichel-Streiber, C., Mann, M., & Aktories, K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13932 · Cited by 478
Clabots, C. R., Johnson, S., Olson, M. M., Peterson, L. R., & Gerding, D. N. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/166.3.561 · Cited by 476
Clindamycin-Associated Colitis Due to a Toxin-Producing Species of Clostridium in Hamsters
Bartlett, J. G., Onderdonk, A. B., Cisneros, R. L., & Kasper, D. L. (1977) · Journal of Infectious Diseases · doi:10.1093/infdis/136.5.701 · Cited by 472
Wistrom, J. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.1.43 · Cited by 448
Clostridium difficile–Associated Diarrhea
Johnson, S., & Gerding, D. N. (1998) · Clinical Infectious Diseases · doi:10.1086/520276 · Cited by 441
Clostridium difficile Infection
Kelly, C. P., & LaMont, J. T. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.375 · Cited by 420
Antibiotic-Associated Diarrhea
Bartlett, J. G. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.4.573 · Cited by 414
Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea
Shim, J. K., Johnson, S., Samore, M. H., Bliss, D. Z., & Gerding, D. N. (1998) · The Lancet · doi:10.1016/s0140-6736(97)08062-8 · Cited by 391
Johnson, S., Samore, M. H., Farrow, K. A., Killgore, G. E., Tenover, F. C., Lyras, D., Rood, J. I., DeGirolami, P., Baltch, A. L., Rafferty, M. E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911253412203 · Cited by 379
Fekety, R., McFarland, L. V., Surawicz, C. M., Greenberg, R. N., Elmer, G. W., & Mulligan, M. E. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.3.324 · Cited by 376
(1992) · American Journal of Infection Control · doi:10.1016/s0196-6553(05)80130-0 · Cited by 363
Johnson, S., Homann, S. R., Bettin, K. M., Quick, J. N., Clabots, C. R., Peterson, L. R., & Gerding, D. N. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-4-297 · Cited by 355
Epidemiology of Recurrences or Reinfections of Clostridium difficile -Associated Diarrhea
Barbut, F., Richard, A., Hamadi, K., Chomette, V., Burghoffer, B., & Petit, J.-C. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.6.2386-2388.2000 · Cited by 355
Diagnosis and Treatment of Clostridium difficile Colitis
Fekety, R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500010081036 · Cited by 354
Samore, M. H., Venkataraman, L., DeGirolami, P. C., Arbeit, R. D., & Karchmer, A. W. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)90008-x · Cited by 350
Mechanisms and Management of Antibiotic‐Associated Diarrhea
Hogenauer, C., Hammer, H. F., Krejs, G. J., & Reisinger, E. C. (1998) · Clinical Infectious Diseases · doi:10.1086/514958 · Cited by 348
Riegler, M., Sedivy, R., Pothoulakis, C., Hamilton, G., Zacherl, J., Bischof, G., Cosentini, E., Feil, W., Schiessel, R., & LaMont, J. T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117885 · Cited by 340
Nosocomial Clostridium difficile colonisation and disease
Johnson, S., Clabots, C. R., Linn, F. V., Olson, M. M., Peterson, L. R., Gerding, D. N., Johnson, S., Linn, F. V., Peterson, L. R., & Gerding, D. N. (1990) · The Lancet · doi:10.1016/0140-6736(90)91605-a · Cited by 340
Olson, M. M., Shanholtzer, C. J., Lee, J. T., & Gerding, D. N. (1994) · Infection Control & Hospital Epidemiology · doi:10.1086/646934 · Cited by 339
Definition of the single integration site of the pathogenicity locus in Clostridium difficile
Braun, V., Hundsberger, T., Leukel, P., Sauerborn, M., & von Eichel-Streiber, C. (1996) · Gene · doi:10.1016/s0378-1119(96)00398-8 · Cited by 330
Bolton, R. P., & Culshaw, M. A. (1986) · Gut · doi:10.1136/gut.27.10.1169 · Cited by 320
Epidemiology of antibiotic-associated colitis
Fekety, R., Kim, K.-H., Brown, D., Batts, D. H., Cudmore, M., & Silva, J. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90553-2 · Cited by 300
Clostridium difficile Infection Associated with Antineoplastic Chemotherapy: A Review
Anand, A., & Glatt, A. E. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.1.109 · Cited by 295
Fekety, R., Silva, J., Kauffman, C., Buggy, B., & Gunner Deery, H. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90223-4 · Cited by 293
Environmental Control to Reduce Transmission of Clostridium difficile
Mayfield, J. L., Leet, T., Miller, J., & Mundy, L. M. (2000) · Clinical Infectious Diseases · doi:10.1086/318149 · Cited by 279
Leung, D. Y. M., Kelly, C. P., Boguniewicz, M., Pothoulakis, C., LaMont, J. T., & Flores, A. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83393-1 · Cited by 278
Intravenous immunoglobulin therapy for severe Clostridium difficile colitis
Salcedo, J., Keates, S., Pothoulakis, C., Warny, M., Castagliuolo, I., LaMont, J. T., & Kelly, C. P. (1997) · Gut · doi:10.1136/gut.41.3.366 · Cited by 264
Large clostridial cytotoxins — a family of glycosyltransferases modifying small GTP-binding proteins
VONEICHELSTREIBER, C., BOQUET, P., SAUERBORN, M., & THELESTAM, M. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)10061-5 · Cited by 256
ACQUISITION OF CLOSTRIDIUM DIFFICILE FROM THE HOSPITAL ENVIRONMENT1
KAATZ, G. W., GITLIN, S. D., SCHABERG, D. R., WILSON, K. H., KAUFFMAN, C. A., SEO, S. M., & FEKETY, R. (1988) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114921 · Cited by 247
Financial burden of hospital-acquired Clostridium difficile infection
Wilcox, M. H., Cunniffe, J. G., Trundle, C., & Redpath, C. (1996) · Journal of Hospital Infection · doi:10.1016/s0195-6701(96)90122-x · Cited by 244
ORAL VANCOMYCIN FOR ANTIBIOTIC-ASSOCIATED PSEUDOMEMBRANOUS COLITIS
Tedesco, F., Gurwith, M., Markham, R., Christie, D., & Bartlett, J. (1978) · The Lancet · doi:10.1016/s0140-6736(78)91741-5 · Cited by 243
Epidemiology of Community-Acquired Clostridium difficile-Associated Diarrhea
Hirschhorn, L. R., Trnka, Y., Onderdonk, A., Lee, M.-L. T., & Platt, R. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.1.127 · Cited by 237
Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection
Warny, M., Vaerman, J. P., Avesani, V, & Delmée, M. (1994) · Infection and Immunity · doi:10.1128/iai.62.2.384-389.1994 · Cited by 230
The effect of probiotics on clostridium difficile diarrhea
POCHAPIN, M. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00809-6 · Cited by 227
Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis.
Tedesco, F. J., Gordon, D., & Fortson, W. C. (1985) · PubMed · Cited by 217
Serum Antibody Response to Toxins A and B of Clostridium difficile
Viscidi, R., Laughon, B. E., Yolken, R., Bo-Linn, P., Moench, T., Ryder, R. W., & Bartlett, J. G. (1983) · Journal of Infectious Diseases · doi:10.1093/infdis/148.1.93 · Cited by 204
Eglow, R., Pothoulakis, C., Itzkowitz, S., Israel, E. J., O'Keane, C. J., Gong, D., Gao, N., Xu, Y. L., Walker, W. A., & LaMont, J. T. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115957 · Cited by 197
Hospital disinfectants and spore formation by Clostridium difficile
Wilcox, M. H., & Fawley, W. N. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02819-1 · Cited by 185
Recurrence of symptoms in Clostridium difficile infection—relapse or reinfection?
Wilcox, M. H., Fawley, W. N., Settle, C. D., & Davidson, A. (1998) · Journal of Hospital Infection · doi:10.1016/s0195-6701(98)90062-7 · Cited by 175
Young, G. P., Ward, P. B., Bayley, N., Gordon, D., Higgins, G., Trapani, J. A., McDonald, M. I., Labrooy, J., & Hecker, R. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90206-9 · Cited by 171
Lewis, S. J., Potts, L. F., & Barry, R. E. (1998) · Journal of Infection · doi:10.1016/s0163-4453(98)80008-x · Cited by 171
Clostridium difficile: clinical disease and diagnosis
Knoop, F. C., Owens, M., & Crocker, I. C. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.3.251 · Cited by 171
Nitazoxanide: pharmacokinetics and metabolism in man
Broekhuysen, J., Stockis, A., Lins, R. L., Graeve, J. D., & Rossignol, J. F. (2000) · Int. Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp38387 · Cited by 168
Kink, J. A., & Williams, J. A. (1998) · Infection and Immunity · doi:10.1128/iai.66.5.2018-2025.1998 · Cited by 159
Dubreuil, L. J., Houcke, I., Mouton, Y., & Rossignol, J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2266 · Cited by 149
Johnson, S., Kent, S. A., O’Leary, K. J., Merrigan, M. M., Sambol, S. P., Peterson, L. R., & Gerding, D. N. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00012 · Cited by 148
Barbut, F., Kajzer, C., Planas, N., & Petit, J. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.4.963-967.1993 · Cited by 142
Epidemiology, clinical manifestations, and outcome of Clostridium difficile-associated diarrhea.
Anand, A., Bashey, B., Mir, T., & Glatt, A. E. (1994) · PubMed · Cited by 138
Kim, P. H., Iaconis, J. P., & Rolfe, R. D. (1987) · Infection and Immunity · doi:10.1128/iai.55.12.2984-2992.1987 · Cited by 136
Lyerly, D. M., Bostwick, E. F., Binion, S. B., & Wilkins, T. D. (1991) · Infection and Immunity · doi:10.1128/iai.59.6.2215-2218.1991 · Cited by 136
Nair, S. P., Yadav, D. K., Corpuz, M. O., & Pitchumoni, C. S. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.00541.x · Cited by 130
Wilcox, M. H., & Howe, R. A. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/36.4.673 · Cited by 122
Pseudomembranous colitis: a surgical disease?
Lipsett, P. A., Samantaray, D. K., Tam, M., Bartlett, J. G., & Lillemoe, K. D. (1994) · PubMed · Cited by 121
Warny, M., Fatimi, A., Bostwick, E. F., Laine, D. C., Lebel, F., LaMont, J. T., Pothoulakis, C., & Kelly, C. P. (1999) · Gut · doi:10.1136/gut.44.2.212 · Cited by 119
Kelly, C. P., Pothoulakis, C., Orellana, J., & LaMont, J. T. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91781-x · Cited by 118
Pseudomembranous Colitis Caused by a Toxin A − B + Strain of Clostridium difficile
Limaye, A. P., Turgeon, D. K., Cookson, B. T., & Fritsche, T. R. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.4.1696-1697.2000 · Cited by 117
The Role of Physical Proximity in Nosocomial Diarrhea
Chang, V. T.-S., & Nelson, K. E. (2000) · Clinical Infectious Diseases · doi:10.1086/314030 · Cited by 117
Aronsson, B., Granström, M., Möllby, R., & Nord, C. E. (1985) · Infection · doi:10.1007/bf01642866 · Cited by 114
Giannasca, P. J., Zhang, Z., Lei, W.-D., Boden, J. A., Giel, M. A., Monath, T. P. C., & Thomas, W. D. (1999) · Infection and Immunity · doi:10.1128/iai.67.2.527-538.1999 · Cited by 113
Corthier, G., Muller, M. C., Wilkins, T. D., et al. (1991) · Infection and Immunity · doi:10.1128/iai.59.3.1192-1195.1991 · Cited by 111
In Vitro and In Vivo Activities of Nitazoxanide against Clostridium difficile
McVay, C. S., & Rolfe, R. D. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2254-2258.2000 · Cited by 111
Kelly, C. P., Chetham, S., Keates, S. E., Bostwick, E. F., Roush, A. M., Castagliuolo, I., LaMont, J. T., & Pothoulakis, C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.2.236 · Cited by 103
Rectal Sparing in Antibiotic-Associated Pseudomembranous Colitis: A Prospective Study
Tedesco, F. J., Corless, J. K., & Brownstein, R. E. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80136-4 · Cited by 102
Ryan, E. T., Butterton, J. R., Smith, R. N., Carroll, P. A., Crean, T. I., & Calderwood, S. B. (1997) · Infection and Immunity · doi:10.1128/iai.65.7.2941-2949.1997 · Cited by 100
Self-citationJefferson, K. K., Smith, M. F., & Bobak, D. A. (1999) · PubMed · Cited by 99
Dzink-Fox, J., & Bartlett, J. G. (1980) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.17.4.695 · Cited by 98
Kelly, C. P., Pothoulakis, C., Vavva, F., Castagliuolo, I., Bostwick, E. F., O’Keane, J. C., Keates, S. E., & LaMont, J. T. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.373 · Cited by 97
Dillon, S. T., Rubin, E. J., Yakubovich, M., et al. (1995) · Infection and Immunity · doi:10.1128/iai.63.4.1421-1426.1995 · Cited by 94
Wanahita, A., Goldsmith, E. A., & Musher, D. M. (2002) · Clinical Infectious Diseases · doi:10.1086/340536 · Cited by 89
Gastrointestinal Side Effects of Clindamycin and Ampicillin Therapy
Lusk, R. H., Fekety, F. R., Silva, J., et al. (1977) · The Journal of Infectious Diseases · doi:10.1093/infdis/135.supplement.s111 · Cited by 84
Clostridium difficile colitis after kidney and kidney‐pancreas transplantation
West, M. A., Pirenne, J., Chavers, B. M., et al. (1999) · Clinical Transplantation · doi:10.1034/j.1399-0012.1999.130407.x · Cited by 82
Risk Factors for Early RecurrentClostridium difficile–Associated Diarrhea
Do, A. N., Fridkin, S. K., Yechouron, A., Banerjee, S. N., Killgore, G., Bourgault, A., Jolivet, M., & Jarvis, W. R. (1998) · Clinical Infectious Diseases · doi:10.1086/513952 · Cited by 82
Laparotomy for Fulminant Pseudomembranous Colitis
Medich, D. (1992) · Archives of Surgery · doi:10.1001/archsurg.1992.01420070111020 · Cited by 80
Community-Acquired Clostridium difficile-Associated Diarrhea
Riley, T. V., Cooper, M., Bell, B., & Golledge, C. L. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.supplement_2.s263 · Cited by 79
CLOSTRIDIUM DIFFICILE COLITIS AND DIARRHEA
Pothoulakis, C., & LaMont, J. T. (1993) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(21)00093-5 · Cited by 76
Ward, S., Douce, G. R., Figueiredo, D. M. M., Dougan, G., & Wren, B. W. (1999) · Infection and Immunity · doi:10.1128/iai.67.5.2145-2152.1999 · Cited by 74
Frey, S. M., & Wilkins, T. D. (1992) · Infection and Immunity · doi:10.1128/iai.60.6.2488-2492.1992 · Cited by 72
Prevention of clindamycin-induced colitis in hamsters by Clostridium sordellii antitoxin
Allo, M. D., Silva, J., Fekety, R., Rifkin, G. D., & Waskin, H. A. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90345-7 · Cited by 69
Oral immunoglobulin A supplement in treatment of Clostridium difficile enteritis
Tjellström, B., Stenhammar, L., Eriksson, S., & Magnusson, K. (1993) · The Lancet · doi:10.1016/0140-6736(93)90477-x · Cited by 65
Lozniewski, A., Rabaud, C., Dotto, E., et al. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.5.1996-1998.2001 · Cited by 64
Peterson, L. R., Kelly, P. J., & Nordbrock, H. A. (1996) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01695667 · Cited by 60
Treatment of Clostridium difficile diarrhoea with brewer's yeast
Schellenberg, D. M., Bonington, A., Champion, C., Lancaster, R., Webb, S., & Main, J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90960-1 · Cited by 59
Cleaning up Clostridium difficile infection
Wilcox, M. H. (1996) · The Lancet · doi:10.1016/s0140-6736(05)65204-x · Cited by 57
Randomized controlled trial of colestipol in antibiotic-associated colitis
Mogg, G. A. G., GEORGE, R. H., Youngs, D. J., Johnson, M., Thompson, H., Burdon, D. W., & Keighley, M. R. B. (1982) · British journal of surgery · doi:10.1002/bjs.1800690306 · Cited by 56
Clostridium difficile-Associated Diarrhea in HIV-Infected Patients: Epidemiology and Risk Factors
Barbut, F., Meynard, J., Guiguet, M., Avesani, V., Bochet, M., Meyohas, M., Delmée, M., Tilleul, P. R., Frottier, J., & Petit, J. (1997) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199711010-00006 · Cited by 55
Genetic Characterization of Toxin A-Negative, Toxin B-Positive Clostridium difficile Isolates by PCR
Moncrief, J. S., Zheng, L., Neville, L. M., & Lyerly, D. M. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.8.3072-3075.2000 · Cited by 55
Whittier, S., Shapiro, D. S., Kelly, W. F., Walden, T. P., Wait, K. J., McMillon, L. T., & Gilligan, P. H. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.11.2861-2865.1993 · Cited by 51
Clostridium difficile-associated diarrhoea: epidemiological data from Western Australia
Riley, T. V., O'Neill, G. L., Bowman, R. A., & Golledge, C. L. (1994) · Epidemiology and Infection · doi:10.1017/s0950268800051414 · Cited by 49
Lyerly, D. M., Johnson, J. L., Frey, S. M., & Wilkins, T. D. (1990) · Current Microbiology · doi:10.1007/bf02090096 · Cited by 49
Wilcox, M. H., Fawley, W. N., Freeman, J., & Brayson, J. C. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.4.551 · Cited by 49
Ward, S., Douce, G. R., Dougan, G., & Wren, B. W. (1999) · Infection and Immunity · doi:10.1128/iai.67.10.5124-5132.1999 · Cited by 46
Wren, B. W., Russell, R. R. B., & Tabaqchali, S. (1991) · Infection and Immunity · doi:10.1128/iai.59.9.3151-3155.1991 · Cited by 41
Clostridium difficile infection: pathophysiology and diagnosis.
Bartlett, J. G. (1997) · PubMed · Cited by 41
Pharmacodynamics of metronidazole determined by a time-kill assay for Trichomonas vaginalis
Nix, D. E., Tyrrell, R. M., & Müller, M. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.8.1848 · Cited by 38
Clostridium difficile Diarrhea After Use of Tacrolimus Following Renal Transplantation
Sharma, A. K., & Holder, F. E. (1998) · Clinical Infectious Diseases · doi:10.1086/517744 · Cited by 34
toxin and faecal lactoferrin assays in adult patients
Vaishnavi, C. V., Bhasin, D. K., Kochhar, R. K., & Singh, K. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)01343-5 · Cited by 32
Ketley, J. M., Mitchell, T. J., Candy, D. C. A., Burdon, D. W., & Stephen, J. (1987) · Journal of Medical Microbiology · doi:10.1099/00222615-24-1-41 · Cited by 32
Cohen, S. H., Tang, Y. J., Rahmani, D., & Silva, J. (2000) · Clinical Infectious Diseases · doi:10.1086/313807 · Cited by 26
Diagnosis of Clostridium difficile-associated disease: Patient selection and test perfection
Gerding, D. N. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(95)00057-7 · Cited by 23
Clostridium difficile in antibiotic associated pediatric diarrhea.
Dutta, P., Niyogi, S. K., Mitra, U., Rasaily, R., Bhattacharya, M. K., Chakraborty, S., & Mitra, A. (1994) · PubMed · Cited by 16
Cited by
Antibiotic-Associated Diarrhea
Bartlett, J. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011603 · Cited by 1,197
Pepin, J. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041104 · Cited by 1,128
Breaking The Cycle: Treatment Strategies for 163 Cases of Recurrent Clostridium Difficile Disease
McFarland, L. V., Elmer, G. W., & Surawicz, C. M. (2002) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05839.x · Cited by 724
Reproducible Community Dynamics of the Gastrointestinal Microbiota following Antibiotic Perturbation
Antonopoulos, D. A., Huse, S. M., Morrison, H. G., Schmidt, T. M., Sogin, M. L., & Young, V. B. (2009) · Infection and Immunity · doi:10.1128/iai.01520-08 · Cited by 550
Relatively Poor Outcome after Treatment of Clostridium difficile Colitis with Metronidazole
Musher, D. M., Aslam, S., Logan, N., Nallacheru, S., Bhaila, I., Borchert, F., & Hamill, R. J. (2005) · Clinical Infectious Diseases · doi:10.1086/430311 · Cited by 504
Metadata
- Authors
- Mylonakis, E., Ryan, E. T., & Calderwood, S. B.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2001-02-26
- Volume
- 161
- Issue
- 4
- Pages
- 525
- ISSN
- 0003-9926
- OpenAlex
- W2064915861
- Cited by
- 339
- References
- 118
- FWCI
- 14.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.